We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
T. Rowe Price Reports 1.8% Sequential Rise in October AUM
Read MoreHide Full Article
T. Rowe Price Group, Inc. (TROW - Free Report) has announced preliminary assets under management (AUM) of $1.15 trillion for October 2019. Results reflect nearly 1.8% rise from the $1.13 trillion recorded as of Sep 30, 2019.
Client transfers from mutual funds to other portfolios, including trusts and separate accounts, were $1.1 billion in October.
Month-end total sponsored U.S. mutual funds came in at $652 billion, up 1.4% from September 2019. Of the total sponsored U.S. mutual funds, around 80% was from stock and blended assets, while the remaining came in from fixed income and money market.
Total other investment portfolios were $493 billion, reflecting 2.1% increase from the previous month. Overall, stock and blended assets accounted for $382 billion or 77% of other investment portfolios, while money-market and fixed income came in at $111 billion or 23%.
T. Rowe Price recorded $277 billion in target date-retirement portfolios, up 1.8% from the $272 billion registered in the prior month.
Our Viewpoint
Although regulatory restrictions and sluggish economic recovery might impair the company’s growth and escalate costs, T. Rowe Price’s diverse and efficient business model is anticipated to boost its AUM. Also, its organic growth remains impressive, as indicated by continued growth in revenues.
So, we believe, driven by these, the stock has gained 15% in the past three months compared with 11.9% growth recorded by the industry.
Among other investment managers, Invesco’s (IVZ - Free Report) preliminary month-end AUM was $1,195.2 billion, up 0.9% from the prior month. This upswing stemmed from favorable market returns, and reinvested distributions. Also, favorable foreign-exchange movement boosted the month’s AUM by $5 billion. These were partly offset by outflows in long-term AUM, money market, and non-management fee earning AUM.
Franklin Resources (BEN - Free Report) has also announced preliminary AUM by its subsidiaries of $693.1 billion for October 2019. Results displayed marginal increase from the $692.6 billion recorded as of Sep 30, 2019. Slight net outflows were offset by net market gains. Further, the reported figure inched up 1.5% year on year.
Cohen & Steers (CNS - Free Report) reported preliminary AUM of $72 billion as of Oct 31, 2019, up 1.6% from the prior-month level of $70.9 billion. Market appreciation of $967 million and net inflows of $333 million were partly offset by distributions of $186 million.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
T. Rowe Price Reports 1.8% Sequential Rise in October AUM
T. Rowe Price Group, Inc. (TROW - Free Report) has announced preliminary assets under management (AUM) of $1.15 trillion for October 2019. Results reflect nearly 1.8% rise from the $1.13 trillion recorded as of Sep 30, 2019.
Client transfers from mutual funds to other portfolios, including trusts and separate accounts, were $1.1 billion in October.
Month-end total sponsored U.S. mutual funds came in at $652 billion, up 1.4% from September 2019. Of the total sponsored U.S. mutual funds, around 80% was from stock and blended assets, while the remaining came in from fixed income and money market.
Total other investment portfolios were $493 billion, reflecting 2.1% increase from the previous month. Overall, stock and blended assets accounted for $382 billion or 77% of other investment portfolios, while money-market and fixed income came in at $111 billion or 23%.
T. Rowe Price recorded $277 billion in target date-retirement portfolios, up 1.8% from the $272 billion registered in the prior month.
Our Viewpoint
Although regulatory restrictions and sluggish economic recovery might impair the company’s growth and escalate costs, T. Rowe Price’s diverse and efficient business model is anticipated to boost its AUM. Also, its organic growth remains impressive, as indicated by continued growth in revenues.
So, we believe, driven by these, the stock has gained 15% in the past three months compared with 11.9% growth recorded by the industry.
T. Rowe currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Competitive Landscape
Among other investment managers, Invesco’s (IVZ - Free Report) preliminary month-end AUM was $1,195.2 billion, up 0.9% from the prior month. This upswing stemmed from favorable market returns, and reinvested distributions. Also, favorable foreign-exchange movement boosted the month’s AUM by $5 billion. These were partly offset by outflows in long-term AUM, money market, and non-management fee earning AUM.
Franklin Resources (BEN - Free Report) has also announced preliminary AUM by its subsidiaries of $693.1 billion for October 2019. Results displayed marginal increase from the $692.6 billion recorded as of Sep 30, 2019. Slight net outflows were offset by net market gains. Further, the reported figure inched up 1.5% year on year.
Cohen & Steers (CNS - Free Report) reported preliminary AUM of $72 billion as of Oct 31, 2019, up 1.6% from the prior-month level of $70.9 billion. Market appreciation of $967 million and net inflows of $333 million were partly offset by distributions of $186 million.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>